Novartis gets FDA approval for skin cancer drug combination
November 20, 2015 at 18:10 PM EST
Nov 20 (Reuters) - Novartis AG said on Friday it received the U.S. Food and Drug Administration's regular approval for a drug combination to treat an aggressive form of skin cancer.
